<DOC>
	<DOC>NCT00589654</DOC>
	<brief_summary>Very little is known about the incidence, onset, time course, and symptomatology of premature menopause induced by breast cancer therapy. No prospective study exists. The purpose of the present study is to identify determinants of treatment-related amenorrhea nad its effect on quality of life in a cohort of youg breast cancer patients.</brief_summary>
	<brief_title>Menstrual Cycle Maintenance and Quality of Life: A Prospective Study</brief_title>
	<detailed_description />
	<mesh_term>Amenorrhea</mesh_term>
	<criteria>Noninstitutional (community dwelling) woman of any race Between 1845 years at the first screening visit Have regular menstrual cycles Diagnosed with invasive breast cancer stage I, II, III within the previous eight months Have physician agreement for patient participation No menstrual bleeding cycles Psychiatric or psychologic abnormality precluding the informed consent process or which would decrease compliance Previous malignancy (excepting basal and squamous skin cancer and stage 0 cervical cancer) Stage IV breast malignancy Residency outside United States No telephone</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>amenorrhea</keyword>
	<keyword>menstrual cycle</keyword>
	<keyword>Breast cancer</keyword>
	<keyword>questionnaire</keyword>
	<keyword>97-127</keyword>
</DOC>